Background: The optimal ablation approach for the treatment of persistent atrial fibrillation (AF) is still under debate; however, the identification and elimination of AF sources is thought to play a key role. Currently available technologies for the identification of AF sources are not able to differentiate between active rotors or focal impulse (FI) and passive circular turbulences as generated by the interaction of a wave front with a functional obstacle such as fibrotic tissue.
Objectives: This study introduces electrographic flow (EGF) mapping as a novel technology for the identification and characterization of AF sources in humans.
Methods: Twenty-five patients with AF (persistent: n = 24, long-standing persistent: n = 1; mean age 70.0 ± 8.3 years, male: n = 17) were included in this prospective study. Focal impulse and Rotor-Mapping (FIRM) was performed in addition to pulmonary vein isolation using radiofrequency in conjunction with a 3D-mapping-system. One-minute epochs were exported from the EP-recording-system and re-analyzed using EGF mapping after the procedure.
Results: 44 potential AF sources (43 rotors and one FI) were identified with FIRM and 39 of these rotors were targeted for ablation. EGF mapping verified 40 of these patterns and identified 24/40 (60%) as active sources while 16/40 (40%) were classified as passive circular turbulences. Four rotors were not identified by EGF mapping.
Conclusion: EGF is the first method to identify active AF sources during AF ablation procedures in humans and discriminate them from passive rotational phenomena, which occur if the excitation wavefront passes conduction bariers. EGF mapping may allow improved guidance of AF ablation procedures.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00392-018-1274-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A single-center trial of electrographic flow mapping and concomitant voltage mapping in sinus rhythm and atrial fibrillation (FLOW EVAL-AF).
J Interv Card Electrophysiol
November 2024
Cortex Inc, Menlo Park, CA, USA.
Article Synopsis
- Electrographic flow (EGF) mapping is a technique used to understand how electrical signals move in the heart's atria, especially in relation to atrial fibrillation (AF) compared to normal sinus rhythm (SR).
- The study involved mapping electrical activity in the atria of ten patients, showing that EGF patterns differ significantly in AF, with lower electrographic flow consistency (EGFC) during AF compared to SR, indicating more chaotic activity.
- The findings suggest EGFC could serve as a valuable marker for assessing atrial health and myopathy, correlating with bipolar voltage measurements, which are commonly used to evaluate heart conditions.
Identifying the HIV-Resistance-Related Factors and Regulatory Network via Multi-Omics Analyses.
Int J Mol Sci
November 2024
School of Life Sciences, Chongqing University, No. 55 Daxuecheng South Road, Shapingba, Chongqing 401331, China.
For research on HIV/AIDS, it is important to elucidate the complex viral-host interaction, host dependency factors (HDFs), and restriction factors. However, the regulatory network of HIV-resistance-related factors remains not well understood. Therefore, we integrated four publicly available HIV-related transcriptome datasets, along with three datasets on HIV-infection-related DNA methylation, miRNA, and ChIP-seq, to predict the factors influencing HIV resistance and infection.
View Article and Find Full Text PDFPhosphoproteomic response to epidermal growth factor in native rat inner medullary collecting duct.
Am J Physiol Renal Physiol
January 2025
Epithelial Systems Biology Laboratory, Systems Biology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States.
Epidermal growth factor (EGF) has important effects in the renal collecting duct to regulate salt and water transport. To identify elements of EGF-mediated signaling in the rat renal inner medullary collecting duct (IMCD), we carried out phosphoproteomic analysis. Biochemically isolated rat IMCD suspensions were treated with 1 µM of EGF or vehicle for 30 min.
View Article and Find Full Text PDFExtracellular proximal interaction profiling by cell surface-targeted TurboID reveals LDLR as a partner of liganded EGFR.
Sci Signal
November 2024
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Sinai Health, Toronto, Canada.
Plasma membrane proteins play pivotal roles in receiving and transducing signals from other cells and from the environment and are vital for cellular functionality. Enzyme-based, proximity-dependent approaches, such as biotin identification (BioID), combined with mass spectrometry have begun to illuminate the landscape of proximal protein interactions within intracellular compartments. To extend the potential of these approaches to study the extracellular environment, we developed extracellular TurboID (ecTurboID), a method designed to profile the interactions between proteins on the surfaces of living cells over short timescales using the fast-acting biotin ligase TurboID.
View Article and Find Full Text PDFPVI-only is not enough for all patients with persistent AF: A FLOW-AF subgroup analysis.
Heart Rhythm
October 2024
Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York.
Background: Since the Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial Part II (STAR-AF II), there has been a trend toward pulmonary vein isolation (PVI)-only ablation strategies for persistent atrial fibrillation (PeAF). Electrographic flow (EGF) mapping can identify active sources of atrial fibrillation (AF) and estimate the electrographic flow consistency (EGFC) of wavefront propagation through substrate, revealing functional AF mechanisms.
Objective: We sought to examine the success of a PVI-only ablation strategy for a redo PeAF/longstanding PeAF population.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!